BACKGROUND: To study withdrawal, ethanol is usually administered chronically without interruption. However, interest has recurred in models of episodic exposure. Increasing evidence suggests that chronic intermittent exposure to ethanol leads to a sensitization effect in both withdrawal severity and ethanol consumption. The goal of the present study was to examine mouse inbred strain differences in withdrawal severity following chronic intermittent exposure using the handling-induced convulsion as the behavioral endpoint. We also sought to compare the withdrawal responses of inbred strains across acute, chronic continuous, and chronic intermittent exposure regimens. METHODS: Male mice from 15 standard inbred strains were exposed to ethanol vapor for 16 hours each day for 3 days and removed to an air chamber during the intervening 8 hours. Mice in the control groups were handled the same, except that they were exposed only to air. Daily blood ethanol concentrations were averaged for each mouse to estimate total dose of ethanol experienced. RESULTS: Across strains, mice had an average daily blood ethanol concentration (BEC) of 1.45 +/- 0.02 mg/ml and we restricted the range of this value to 1.00-2.00 mg/ml. To evaluate strain differences, we divided data into two dose groups based on BEC, low dose (1.29 +/- 0.1 mg/ml) and high dose (1.71 +/- 0.02 mg/ml). After the third inhalation exposure, ethanol-exposed and air-exposed groups were tested hourly for handling-induced convulsions for 10 hour and at hour 24 and 25. Strains differed markedly in the severity of withdrawal (after subtraction of air control values) in both dose groups. CONCLUSION: The chronic intermittent exposure paradigm is sufficient to elicit differential withdrawal responses across nearly all strains. Data from the high-dose groups correlated well with withdrawal data derived from prior acute (single high dose) and chronic continuous (for 72 hours) ethanol withdrawal studies, supporting the influence of common genes on all three responses.
BACKGROUND: To study withdrawal, ethanol is usually administered chronically without interruption. However, interest has recurred in models of episodic exposure. Increasing evidence suggests that chronic intermittent exposure to ethanol leads to a sensitization effect in both withdrawal severity and ethanol consumption. The goal of the present study was to examine mouse inbred strain differences in withdrawal severity following chronic intermittent exposure using the handling-induced convulsion as the behavioral endpoint. We also sought to compare the withdrawal responses of inbred strains across acute, chronic continuous, and chronic intermittent exposure regimens. METHODS: Male mice from 15 standard inbred strains were exposed to ethanol vapor for 16 hours each day for 3 days and removed to an air chamber during the intervening 8 hours. Mice in the control groups were handled the same, except that they were exposed only to air. Daily blood ethanol concentrations were averaged for each mouse to estimate total dose of ethanol experienced. RESULTS: Across strains, mice had an average daily blood ethanol concentration (BEC) of 1.45 +/- 0.02 mg/ml and we restricted the range of this value to 1.00-2.00 mg/ml. To evaluate strain differences, we divided data into two dose groups based on BEC, low dose (1.29 +/- 0.1 mg/ml) and high dose (1.71 +/- 0.02 mg/ml). After the third inhalation exposure, ethanol-exposed and air-exposed groups were tested hourly for handling-induced convulsions for 10 hour and at hour 24 and 25. Strains differed markedly in the severity of withdrawal (after subtraction of air control values) in both dose groups. CONCLUSION: The chronic intermittent exposure paradigm is sufficient to elicit differential withdrawal responses across nearly all strains. Data from the high-dose groups correlated well with withdrawal data derived from prior acute (single high dose) and chronic continuous (for 72 hours) ethanol withdrawal studies, supporting the influence of common genes on all three responses.
Authors: Michelle A Nipper; Jeremiah P Jensen; Melinda L Helms; Matthew M Ford; John C Crabbe; David J Rossi; Deborah A Finn Journal: Neuroscience Date: 2018-12-02 Impact factor: 3.590
Authors: John C Crabbe; Alexandre M Colville; Lauren C Kruse; Andy J Cameron; Stephanie E Spence; Jason P Schlumbohm; Lawrence C Huang; Pamela Metten Journal: Alcohol Clin Exp Res Date: 2012-02-06 Impact factor: 3.455
Authors: David J Hinton; Moonnoh R Lee; Taylor L Jacobson; Prasanna K Mishra; Mark A Frye; David A Mrazek; Slobodan I Macura; Doo-Sup Choi Journal: Neuropharmacology Date: 2012-06 Impact factor: 5.250
Authors: Rachel A Daut; Erica F Busch; Jessica Ihne; Daniel Fisher; Masayoshi Mishina; Seth G N Grant; Marguerite Camp; Andrew Holmes Journal: Addict Biol Date: 2014-01-07 Impact factor: 4.280
Authors: Jeremiah P Jensen; Michelle A Nipper; Melinda L Helms; Matthew M Ford; John C Crabbe; David J Rossi; Deborah A Finn Journal: Psychopharmacology (Berl) Date: 2017-06-29 Impact factor: 4.530
Authors: Anushree N Karkhanis; Jamie H Rose; Kimberly N Huggins; Joanne K Konstantopoulos; Sara R Jones Journal: Drug Alcohol Depend Date: 2015-02-16 Impact factor: 4.492